Intelligent Automation, Inc.
<
 
Home>News>2016>Intelligent Automation, Inc. introduces mSMART Medication Aide for Smoking Cessation and HIV PrEP

Intelligent Automation, Inc. introduces mSMART™ Medication Aide for Smoking Cessation and HIV PrEP

Intelligent Automation, Inc. (IAI) announces the release of mSMART™ Medication Aide (https://msmart.i-a-i.com), a cloud-based patient-centered mobile application for improving medication adherence. mSMART™ is designed to educate patients to overcome adherence barrier, encourage patients to change their behavior for long-term adherence, and ensure that patients take medication as prescribed. Patients engage with SMART Desk, an interactive space in mSMART™, to answer brief questions about their adherence behaviors and understanding of the care plan prescribed to them. mSMART’s personalized patient feedback includes examples, long and short-term benefits and treatment costs, outcomes of clinical studies, personal stories, and common symptom management techniques. mSMART™ also utilizes a patient’s smartphone camera to confirm medicine and appropriate dose, and thus frees patients from the stress of remembering complex prescription regimens.

mSMART™ is more than a self-management solution; it is a shared decision-making platform. While mSMART is effective in improving medication and care plan adherence, mSMART™ also keeps track of the most difficult issues and barriers that require attention from healthcare providers. With the mSMART™ portal, providers can manage patient cohorts who need increased adherence, track patient risk to medication discontinuity, and view concise personalized information about a patient’s most difficult issues that needs to be addressed.

mSMART™ is currently available on iOS App Store and Google Play for improved medication adherence of Chantix® for smoking cessation and Truvada® for HIV Pre-Exposure Prophylaxis (PrEP). mSMART™ offers a cloud-based provider portal to access patient behavior reports, or export them to third-party medication management software. IAI is working with Duke University School of Medicine (DUSM) on multiple clinical studies to assess the adherence impact of mSMART™. Future applications of mSMART™ include a Medication Therapy Management (MTM) application to facilitate greater demand for MTM services and reduce the cost of Chronic Care Management (CCM) for the patient, payers, and providers.

About IAI:
Intelligent Automation, Inc. (IAI) is a technology innovation company headquartered in Rockville, MD. We specialize in providing advanced technology solutions and R&D services to federal agencies, and corporations throughout the United States and internationally. Leveraging agile R&D processes, a multi-disciplinary collaborative environment, and its substantial intellectual property portfolio, IAI excels in developing concepts into market-focused products and customer-driven solutions. IAI’s core R&D areas include: Air Traffic Management, Big Data and Social Media Analytics, Control and Signal Processing, Cyber Security, Education and Training Technologies, Health Technologies, Modeling and Simulation, Networks and Communications, Robotics, and Sensor Systems. For more information on IAI, please visit www.i-a-i.com.

Latest News
© 2008-2016 Intelligent Automation, Inc. | 15400 Calhoun Drive, Suite 190, Rockville, MD 20855 | Phone: 301 294 5200 | Fax: 301 294 5201